Boston Scientific Logo

MILESTONE II International Registry

For the MILESTONE II International Registry data in portable document format, click here.
Objective: Established physician's usage patterns by lesion type and patient subsets for the TAXUS® Express2™ Paclitaxel-Eluting Coronary Stent System
Number of Patients: 3,688
Number of Sites: 164 sites in 31 countries
Lesion Type: de novo
Stent Platform: TAXUS® Express2™ Paclitaxel-Eluting Stent
Release Kinetics: Slow
Primary Endpoint: Real world physician usage by lesion type and patient subset
P.I. and Co-P.I.: K. Niemela, MD
Status: Enrollment Complete